HealthEquity (HQY) 8-K Other Events

EXHIBIT 99.2

Interim unaudited condensed consolidated financial statements of WageWorks, Inc.
as of March 31, 2019 and for the three months ended March 31, 2019 and 2018

WAGEWORKS, INC.

Condensed Consolidated Balance Sheets
(In thousands, except per share amounts)

	March 31, 2019			December 31, 2018
	(Unaudited)			Derived from Audited Financial Statements
Assets
Current assets:
Cash and cash equivalents	$	782,766		$	898,426
Restricted cash	333			333
Short-term investments	183,603			222,205
Receivables, net	114,426			101,297
Prepaid expenses and other current assets	30,822			23,662
Total current assets	1,111,950			1,245,923
Property and equipment, net	74,378			76,920
Operating lease right-of-use assets	24,095			—
Goodwill	297,409			297,409
Acquired intangible assets, net	123,762			130,095
Deferred tax assets, net	1,305			1,482
Other assets	33,300			33,324
Total assets	$	1,666,199		$	1,785,153
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable and accrued expenses	$	87,812		$	97,347
Customer obligations	660,437			762,100
Short-term operating lease liabilities	8,069			—
Other current liabilities	19,197			4,264
Total current liabilities	775,515			863,711
Long-term debt, net of issuance costs	184,769			244,693
Long-term operating lease liabilities	28,455			—
Other long-term liabilities	4,773			11,608
Total liabilities	993,512			1,120,012
Commitments and Contingencies (Note 10)
Stockholders’ Equity:
Common stock, par value $0.001 per share (1,000,000 shares authorized; 40,333 shares issued and 39,853 shares outstanding at March 31, 2019 and December 31, 2018)	41			41
Additional paid-in capital	585,478			582,521
Treasury stock at cost (480 shares at March 31, 2019 and December 31, 2018)	(22,309		)	(22,309		)
Accumulated other comprehensive loss	(222		)	(754		)
Retained earnings	109,699			105,642
Total stockholders’ equity	672,687			665,141
Total liabilities and stockholders’ equity	$	1,666,199		$	1,785,153

See accompanying notes to the condensed consolidated financial statements.

WAGEWORKS, INC.
Condensed Consolidated Statements of Income
(In thousands, except per share amounts)
(Unaudited)

	Three Months Ended March 31,
	2019			2018
Revenues:
Healthcare	$	71,974		$	75,256
COBRA	23,589			28,835
Commuter	19,340			18,878
Other	3,322			3,671
Total revenues	118,225			126,640
Operating expenses:
Cost of revenues (excluding amortization of internal use software)	39,258			45,242
Technology and development	16,340			13,033
Sales and marketing	18,331			18,338
General and administrative	27,909			25,249
Amortization	10,851			9,991
Total operating expenses	112,689			111,853
Income from operations	5,536			14,787
Interest and other income, net	2,649			1,266
Interest expense	(2,709		)	(2,182		)
Income before income taxes	5,476			13,871
Income tax provision	(1,419		)	(2,852		)
Net income	$	4,057		$	11,019
Net income per share:
Basic	$	0.10		$	0.28
Diluted	$	0.10		$	0.27
Shares used in computing net income per share:
Basic	39,853			39,823
Diluted	40,437			40,480

See accompanying notes to the condensed consolidated financial statements.

WAGEWORKS, INC.
Condensed Consolidated Statements of Comprehensive Income
(In thousands) (Unaudited)

	Three Months Ended March 31,
	2019		2018
Net income	$	4,057	$	11,019
Other comprehensive income (loss), net of tax:
Net unrealized gain (loss) on short-term investments, net of tax	532		(731		)
Other comprehensive income (loss)	532		(731		)
Total comprehensive income	$	4,589	$	10,288

See accompanying notes to the condensed consolidated financial statements.

WAGEWORKS, INC.
Condensed Consolidated Statements of Stockholders’ Equity
(In thousands) (Unaudited)

	Three Months Ended March 31, 2019
	Common stock			Additional paid-in		Treasury			Accumulated other			Retained		Total stockholders’
	Shares	Amount		capital		stock at cost			comprehensive loss			earnings		equity
Balance at December 31, 2018	39,853	$	41	$	582,521	$	(22,309	)	$	(754	)	$	105,642	$	665,141
Stock-based compensation expense	—	—		2,904		—			—			—		2,904
Capitalized stock-based compensation	—	—		53		—			—			—		53
Other comprehensive income, net of tax	—	—		—		—			532			—		532
Net income	—	—		—		—			—			4,057		4,057
Balance at March 31, 2019	39,853	$	41	$	585,478	$	(22,309	)	$	(222	)	$	109,699	$	672,687

	Three Months Ended March 31, 2018
	Common stock			Additional paid-in			Treasury			Accumulated other comprehensive			Retained		Total stockholders’
	Shares	Amount		capital			stock at cost			loss			earnings		equity
Balance at December 31, 2017	39,771	$	41	$	562,131		$	(22,309	)	$	(354	)	$	72,741	$	612,250
Exercise of stock options	54	—		1,395			—			—			—		1,395
Issuance of common stock under Employee Stock Purchase Plan	18	—		869			—			—			—		869
Issuance of restricted stock units, net of shares withheld for employee taxes	10	—		(281		)	—			—			—		(281		)
Stock-based compensation expense	—	—		7,293			—			—			—		7,293
Capitalized stock-based compensation	—	—		191			—			—			—		191
Other comprehensive loss, net of tax	—	—		—			—			(731		)			(731		)
ASC 606 cumulative-effect adjustment	—	—		—			—			—			6,955		6,955
Net income	—	—		—			—			—			11,019		11,019
Balance at March 31, 2018	39,853	$	41	$	571,598		$	(22,309	)	$	(1,085	)	$	90,715	$	638,960

WAGEWORKS, INC.
Condensed Consolidated Statements of Cash Flows
(In thousands) (Unaudited)

	Three Months Ended March 31,
	2019			2018
Cash flows from operating activities:
Net income	$	4,057		$	11,019
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization	14,592			13,182
Amortization of debt issuance costs	176			120
Amortization of contract costs	725			780
Stock-based compensation expense	2,904			7,293
Provision for doubtful accounts	414			19
Other	233			(1		)
Changes in operating assets and liabilities:
Receivables	(13,543		)	(18,688		)
Prepaid expenses and other current assets	(7,160		)	5,600
Other assets	(701		)	(8,341		)
Accounts payable and accrued expenses	(10,797		)	(9,556		)
Customer obligations	(101,663		)	(35,766		)
Other liabilities	20,575			17,465
Net cash used in operating activities	(90,188		)	(16,874		)
Cash flows from investing activities:
Purchases of property and equipment	(4,353		)	(7,618		)
Purchases of short-term investments	(4,966		)	(99,564		)
Proceeds from sales of short-term investments	2,560			—
Proceeds from maturities of short-term investments	41,495			34,150
Purchases of intangible assets	(60		)	(70		)
Net cash provided by (used in) investing activities	34,676			(73,102		)
Cash flows from financing activities:
Proceeds from exercise of common stock options	—			1,396
Proceeds from issuance of common stock under Employee Stock Purchase Plan	—			869
Payments of debt modification costs	(100		)	—
Payments of debt principal	(60,000		)	—
Payment of finance lease obligations	(48		)	(75		)
Taxes paid related to net share settlement of stock-based compensation arrangements	—			(218		)
Net cash (used in) provided by financing activities	(60,148		)	1,972
Net decrease in cash and cash equivalents, unrestricted and restricted	(115,660		)	(88,004		)
Cash and cash equivalents at beginning of period, unrestricted and restricted	898,759			779,677
Cash and cash equivalents at end of period, unrestricted and restricted	$	783,099		$	691,673
Supplemental cash flow disclosure:
Cash paid during the period for:
Interest	$	2,483		$	1,961
Income taxes	$	268		$	113
Noncash financing and investing activities:
Property and equipment, accrued but not paid	$	1,262		$	4,063
Property and equipment under finance lease	$	—		$	142

See accompanying notes to the condensed consolidated financial statements.

Notes to Condensed Consolidated Financial Statements
(Unaudited)

Note 1    Summary of Business and Significant Accounting Policies

Business

WageWorks, Inc., (together with its subsidiaries, “WageWorks” or the “Company”) was incorporated in the state of Delaware in 2000. The Company is a leader in administering Consumer-Directed Benefits (“CDBs”), which empower employees to lower their healthcare related expenditures while also providing corporate tax advantages for employers.

The Company operates as a single reportable segment on an entity level basis, and considers itself to operate under one operating and reporting segment with healthcare, transit and other employer sponsored programs representing a group of similar products lines. The Company believes that it engages in a single business activity and operates in a single economic environment.

Basis of Presentation

The unaudited interim condensed consolidated financial statements and the related notes have been prepared on the same basis as the audited consolidated financial statements and reflect all adjustments that, in the opinion of management, are necessary for a fair presentation of the results for the interim periods presented in accordance with generally accepted accounting principles in the United States of America (“GAAP”). The results of the interim period presented herein are not necessarily indicative of the results of future periods or annual results for the year ending December 31, 2019.

These unaudited interim condensed consolidated financial statements and the related notes should be read in conjunction with the December 31, 2018 audited financial statements and related notes, together with management’s discussion and analysis of financial condition and results of operations, included in the Company’s Annual Report on Form 10-K. The December 31, 2018 consolidated balance sheet, included in this interim Quarterly Report on Form 10-Q, was derived from audited financial statements.

There have been no material changes to the Company’s critical accounting estimates during the three months ended March 31, 2019. Other than the adoption of ASU 2016-02, “Leases (Topic 842)”, there have been no material changes to the Company’s critical accounting policies during the three months ended March 31, 2019 from the items the Company disclosed in the its Annual Report on Form 10-K for the year ended December 31, 2018.

Reclassifications

Certain prior period amounts have been reclassified to conform to current period presentation including the reclassification of deferred revenue from accounts payable and accrued expenses to other current liabilities in the condensed consolidated balance sheet and statement of cash flows for the three months ending March 31, 2018. There was no impact on the condensed consolidated statements of income.

Principles of Consolidation

The unaudited condensed consolidated financial statements include the accounts of WageWorks, Inc. and its subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.

Use of Estimates

In preparing the condensed consolidated financial statements and related disclosure in conformity with GAAP, and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”), the Company must make estimates and judgments that affect the amounts reported in the Consolidated Financial Statements and accompanying notes. Estimates are used for, but not limited to revenue recognition, allowances for doubtful accounts, useful lives for depreciation and amortization, loss contingencies, income taxes, the assumptions used for stock-based compensation including attainment of performance-based awards, the assumptions used for software and web site development cost classification, and recoverability and impairments of goodwill and long-lived assets and average

Notes to Condensed Consolidated Financial Statements
(Unaudited)

customer life. Actual results may be materially different from those estimates. In making its estimates, the Company considers the current economic and legislative environment.

Leases

The Company leases office space under noncancelable operating leases. Operating lease right-of-use assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As the implicit rate is not readily determinable in most of the Company’s lease agreements, the Company uses its estimated secured incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. Lease expense is recognized on a straight-line basis over the lease term. In addition, the Company made an accounting policy election to keep leases with an initial term of 12 months or less off of the balance sheet.

The Company determines if an arrangement is a lease or contains a lease at inception. The Company applied the short-term lease measurement and recognition exemption in which right-of-use (“ROU”) assets and lease obligations are not recognized for short-term leases. The Company does not have lease agreements with residual value guarantees, sales leaseback terms or material restrictive covenants. The Company has one sublease for which the sublease income was recorded as a reduction to operating lease expense for the three months ended March 31, 2019 and 2018.

The Company has lease agreements that contain both lease and non-lease components. For real estate leases, the Company accounts for lease components together with non-lease components (e.g., common-area maintenance). Amounts recognized as ROU assets related to finance leases are included in property and equipment, net in the accompanying condensed consolidated balance sheets, while related lease liabilities are included in other current liabilities and other long-term liabilities.

Recently Adopted Accounting Guidance

In February 2016, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2016-02, Leases (Topic 842), which requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification will determine whether lease expense is recognized based on an effective interest method or on a straight-line basis over the term of the lease. A lessee is also required to record a right-of-use asset and a lease liability for all leases with a term of greater than 12 months regardless of their classification. Leases with a term of 12 months or less will be accounted for similar to existing guidance for operating lease.

The Company adopted Topic 842 prospectively during the first quarter of 2019. As part of its adoption, the Company elected a package of practical expedients for leases that commenced prior to January 1, 2019 and did not reassess: (i) whether any expired or existing contracts are or contain leases; (ii) lease classification for any expired or existing leases; and (iii) initial direct costs capitalization for any existing leases. The Company recognizes those lease payments in the consolidated statements of income on a straight-line basis over the lease term.

The adoption of Topic 842 resulted in the Company recording $25.5 million of right-of-use lease assets and $38.4 million of lease liabilities as of January 1, 2019. The new standard did not have a significant impact on the condensed consolidated statements of income. See Note 10, Commitments and Contingencies for additional information.

In February 2018, the FASB issued ASU No. 2018-02, “Income Statement - Reporting Comprehensive Income (Topic 220) - Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income” (ASU 2018-02). This standard allows a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the Tax Cuts and Jobs Act and requires certain disclosures about stranded tax effects. The Company adopted ASU 2018-02 in January 1, 2019 and applied it in the period of adoption. The Company did not elect to reclassify any tax effects of the Tax Cuts and Jobs Act on items within accumulated other comprehensive income to retained earnings. The adoption of this standard did not have an effect on the Company’s condensed consolidated financial statements.

7

Notes to Condensed Consolidated Financial Statements
(Unaudited)

In August 2018, the FASB issued ASU No. 2018-15, “Intangibles, Goodwill and Other (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract” (ASU 2018-15). ASU 2018-15 requires implementation costs incurred by customers in cloud computing arrangements to be deferred, if those same costs would be capitalized by a customer in a software licensing arrangement under the internal-use software guidance in ASC 350-40. ASU 2018-15 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019, with early adoption permitted. The Company elected to early adopt the new standard as of March 31, 2019. The adoption of this standard did not have a material effect on the Company’s condensed consolidated financial statements.

Recently Issued Accounting Pronouncements

In June 2016, the FASB issued ASU No. 2016-13, “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” (ASU 2016-13), which amends the FASB’s guidance on the impairment of financial instruments. The ASU adds to GAAP an impairment model (known as the “current expected credit loss model”) that is based on expected losses rather than incurred losses. ASU 2016-13 is effective for annual reporting periods beginning after December 15, 2019, including interim periods within those fiscal years. Early adoption is permitted for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The Company is currently evaluating the timing and impact of adoption on its condensed consolidated financial statements.

In January 2017, the FASB issued ASU No. 2017-04, “Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment”. The amendments eliminate Step 2 from the goodwill impairment test. The annual, or interim, goodwill impairment test is performed by comparing the fair value of a reporting unit with its carrying amount. An impairment charge should be recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. In addition, income tax effects from any tax deductible goodwill on the carrying amount of the reporting unit should be considered when measuring the goodwill impairment loss, if applicable. The amendments also eliminate the requirements for any reporting unit with a zero or negative carrying amount to perform a qualitative assessment and, if it fails that qualitative test, to perform Step 2 of the goodwill impairment test. An entity still has the option to perform the qualitative assessment for a reporting unit to determine if the quantitative impairment test is necessary. The new standard is effective for fiscal years beginning after December 15, 2019, with early adoption permitted. The Company is currently evaluating the timing and impact of adoption on the Company’s condensed consolidated financial statements.

In August 2018, the FASB issued ASU No. 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework-Changes to the Disclosure Requirements for Fair Value Measurement” (ASU 2018-13). The primary focus of ASU 2018-13 is to improve the effectiveness of the disclosure requirements for fair value measurements. The changes affect all companies that are required to include fair value measurement disclosures. In general, the amendments in this standard are effective for all entities for fiscal years and interim periods within those fiscal years, beginning after December 15, 2019. Early adoption is permitted. The Company is currently evaluating the timing and impact of adoption on its condensed consolidated financial statements.

In November 2018, the FASB issued ASU No. 2018-19, “Codification Improvements to Topic 326, Financial Instruments-Credit Losses”. ASU 2018-19 clarifies that receivables arising from operating leases are not within the scope of the credit losses standard, but rather, should be accounted for in accordance with the leases standard. In general, the amendments in this standard are effective for public business entities that meet the definition of a SEC filer for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. The Company is currently evaluating the timing and impact of adoption on its condensed consolidated financial statements.

8

Notes to Condensed Consolidated Financial Statements
(Unaudited)

Note 2    Net Income per Share

The following table sets forth the computation of basic and diluted net income per share (in thousands, except per share data):

	Three months ended March 31,
	2019		2018
Numerator:
Net income	$	4,057	$	11,019
Denominator:
Basic weighted-average shares	39,853		39,823
Effect of potentially dilutive shares:
Weighted-average dilutive stock options, restricted stock and performance restricted stock units, and employee stock purchase plan shares	584		657
Diluted weighted-average shares	40,437		40,480
Net income per share:
Basic	$	0.10	$	0.28
Diluted	$	0.10	$	0.27

For the three months ended March 31, 2019 and 2018, potential shares from stock options and restricted stock units totaling 1.9 million and 1.4 million, respectively, are not included in the computation of diluted earnings per share because their inclusion would have been anti-dilutive.

Note 3    Revenue

The Company generally invoices its customers on a monthly basis with a term of net 30-60 days. The Company applies the practical expedient provided by ASC 606 and does not evaluate contracts of one year or less for the existence of a significant financing component. The Company’s policy is to exclude sales and other indirect taxes when measuring the transaction price of its subscription agreements.

9

Notes to Condensed Consolidated Financial Statements
(Unaudited)

Disaggregation of Revenue

The Company’s primary categories of revenue are Healthcare, Commuter, COBRA and Other revenue and are disclosed in the condensed consolidated statements of income. The following table provides information about disaggregated revenue from contracts with customers by the nature of the products and services (in thousands):

	Three Months Ended March 31,
	2019		2018
Benefit administration services and COBRA	$	95,960	$	104,440
Interchange	15,439		15,745
Other revenue	6,826		6,455
Total	$	118,225	$	126,640

Contract Balances

The Company generally does not recognize revenue in advance of invoicing its customers, however, it records a receivable when revenue is recognized prior to payment and it has unconditional right to payment. Alternatively, when payment precedes the related services, the Company records a contract liability, or deferred revenue, until its performance obligations are satisfied. The Company’s deferred revenue as of March 31, 2019 and December 31, 2018 was $17.1 million and $3.9 million, respectively.

The balances related to cash received in advance for a certain interchange revenue arrangement, other up-front fees and other commuter deferred revenue. The Company expects to satisfy its remaining obligations for these arrangements.

Contract Costs

Contract costs relate to incremental costs of obtaining a contract with a customer. Contract costs, which primarily consist of deferred sales commissions, were $8.7 million and $8.8 million as of March 31, 2019 and December 31, 2018, respectively and are included in other assets on the condensed consolidated balance sheets. Amortization expense for the deferred costs was $0.7 million and $0.8 million for the three months ended March 31, 2019 and 2018, respectively. There was no impairment loss in relation to the costs capitalized for the periods presented. Deferred contract costs are amortized on a straight-line basis over the period of benefit, which is consistent with the pattern of transfer of the good or service to which the asset relates.

10

Notes to Condensed Consolidated Financial Statements
(Unaudited)

Performance Obligations

During the three months ended March 31, 2019, the Company recognized the following revenues (in thousands):

	Three Months Ended March 31, 2019
Revenue recognized in the period for:
Amounts included in contract liabilities at the beginning of the period:
Performance obligations satisfied	$	143
Changes in the period:
Performance obligations satisfied from new activities in the period - contract revenue	118,082
Total revenue	$	118,225

The following table includes estimated revenue expected to be recognized in the future related to performance obligations that are unsatisfied or partially unsatisfied at the end of the reporting period. The Company applies the practical expedient to not disclose information about contracts with original expected durations of one year or less, amounts of variable consideration attributable to the variable consideration allocation exception, or contract renewals that are unexercised as of March 31, 2019 (in thousands):

	March 31, 2019
2019 (remainder of year)	$	429
2020	571
2021	571
2022 and thereafter	1,143
Total	$	2,714

11

Notes to Condensed Consolidated Financial Statements
(Unaudited)

Note 4    Investments and Fair Value Measurements

The following tables summarize the Company’s investments in marketable securities and fair value measurements by investment category reported as cash equivalents and short-term investments as of March 31, 2019 and December 31, 2018 (in thousands):

March 31, 2019	Amortized Cost		Gross Unrealized Gain		Gross Unrealized Loss			Fair Value		Level 1		Level 2
Cash equivalents:
Money market funds	$	40,171	$	—	$	—		$	40,171	$	40,171	$	—
Commercial paper	52,242		—		(9		)	52,233		—		52,233
Municipal bonds	7,742		—		—			7,742		—		7,742
Total cash equivalents	100,155		—		(9		)	100,146		40,171		59,975
Short-Term Investments:
U.S. government securities	19,501		—		(45		)	19,456		19,456		—
U.S. government agency securities	10,826		—		(27		)	10,799		—		10,799
Municipal bonds	2,345		1		—			2,346		—		2,346
Foreign government securities	2,514		—		(1		)	2,513		—		2,513
Corporate debt securities	114,238		116		(233		)	114,121		—		114,121
Commercial paper	4,975		—		(1		)	4,974		—		4,974
Certificates of deposit	—		—		—			—		—		—
Asset-backed securities	29,481		1		(88		)	29,394		—		29,394
Total short-term investments	183,880		118		(395		)	183,603		19,456		164,147
Total cash equivalents and short-term investments	$	284,035	$	118	$	(404	)	$	283,749	$	59,627	$	224,122

12

Notes to Condensed Consolidated Financial Statements
(Unaudited)

December 31, 2018	Amortized Cost		Gross Unrealized Gain		Gross Unrealized Loss			Fair Value		Level 1		Level 2
Cash equivalents:
Money market funds	$	41,027	$	—	$	—		$	41,027	$	41,027	$	—
Commercial paper	10,436		1		—			10,437		—		10,437
Municipal bonds	7,781		—		—			7,781		—		7,781
Total cash equivalents	59,244		1		—			59,245		41,027		18,218
Short-Term Investments:
U.S. government securities	22,534		—		(94		)	22,440		22,440		—
U.S. government agency securities	14,346		—		(56		)	14,290		—		14,290
Municipal bonds	3,548		—		(4		)	3,544		—		3,544
Foreign government securities	2,504		—		(6		)	2,498		—		2,498
Corporate debt securities	134,003		37		(685		)	133,355		—		133,355
Commercial paper	12,954		—		(4		)	12,950		—		12,950
Certificates of deposit	1,258		—		—			1,258		—		1,258
Asset-backed securities	32,054		—		(184		)	31,870		—		31,870
Total short-term investments	223,201		37		(1,033		)	222,205		22,440		199,765
Total cash equivalents and short-term investments	$	282,445	$	38	$	(1,033	)	$	281,450	$	63,467	$	217,983

As of March 31, 2019, the Company’s unrealized losses on investments were deemed temporary in nature.

13

Notes to Condensed Consolidated Financial Statements
(Unaudited)

The following tables summarize the gross unrealized losses and fair values of investments in an unrealized loss position as of March 31, 2019 and December 31, 2018, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position (in thousands).

	Less than 12 months					12 months or greater					Total
March 31, 2019	Fair Value		Gross Unrealized Loss			Fair Value		Gross Unrealized Loss			Fair Value		Gross Unrealized Loss
Cash equivalents:
Commercial paper	$	52,233	$	(9	)	$	—	$	—		$	52,233	$	(9	)
Total cash equivalents in unrealized loss position	52,233		(9		)	—		—			52,233		(9		)
Short-Term Investments:
U.S. government securities	—		—			19,455		(45		)	19,455		(45		)
U.S. government agency securities	1,998		(2		)	8,801		(25		)	10,799		(27		)
Foreign government securities	—		—			2,514		(1		)	2,514		(1		)
Corporate debt securities	10,055		(23		)	71,741		(210		)	81,796		(233		)
Commercial paper	4,974		(1		)	—		—			4,974		(1		)
Asset-backed securities	3,884		(8		)	22,155		(80		)	26,039		(88		)
Total short-term investments in unrealized loss position	20,911		(34		)	124,666		(361		)	145,577		(395		)
Total cash equivalents and short-term investments in unrealized loss position	$	73,144	$	(43	)	$	124,666	$	(361	)	$	197,810	$	(404	)

	Less than 12 months
December 31, 2018	Fair Value		Gross Unrealized Loss
Short-Term Investments:
U.S. government securities	$	22,440	$	(94	)
U.S. government agency securities	14,290		(56		)
Municipal bonds	3,544		(4		)
Foreign government securities	2,498		(6		)
Corporate debt securities	125,192		(685		)
Commercial paper	12,950		(4		)
Asset-backed securities	31,870		(184		)
Total short-term investments in unrealized loss position	$	212,784	$	(1,033	)

14

Notes to Condensed Consolidated Financial Statements
(Unaudited)

Realized gains or losses on marketable securities are included in other income (expense), net on the Company’s condensed consolidated statements of income. Gross realized losses on marketable securities for the three months ended March 31, 2019 and 2018 were not significant.

The Company uses inputs such as actual trade data, benchmark yields, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments. There were no transfers between Level 1 and Level 2 fair value categories during the periods presented.

The following tables summarize the estimated amortized cost and fair value of the Company’s marketable securities by the contractual maturity date as of March 31, 2019 and December 31, 2018 (in thousands):

March 31, 2019	Amortized Cost		Fair Value
Due less than one year	$	248,374	$	248,066
Due in one to five years	35,661		35,683
Total	$	284,035	$	283,749

December 31, 2018	Amortized Cost		Fair Value
Due less than one year	$	219,058	$	218,395
Due in one to five years	63,387		63,055
Total	$	282,445	$	281,450

Note 5    Receivables

Receivables at March 31, 2019 and December 31, 2018 were comprised of the following (in thousands):

	March 31, 2019			December 31, 2018
Trade receivables	$	66,974		$	52,525
Unpaid amounts for benefit services	51,474			52,380
Receivables, gross	118,448			104,905
Less: allowance for doubtful accounts	(4,022		)	(3,608		)
Receivables, net	$	114,426		$	101,297

15

Notes to Condensed Consolidated Financial Statements
(Unaudited)

Note 6    Property and Equipment

Property and equipment at March 31, 2019 and December 31, 2018 were comprised of the following (in thousands):

	March 31, 2019			December 31, 2018
Computers and equipment	$	28,455		$	27,519
Software and software development costs	148,625			144,260
Furniture and fixtures	8,125			8,123
Leasehold improvements	28,895			28,883
	214,100			208,785
Less: accumulated depreciation and amortization	(139,722		)	(131,865		)
Property and equipment, net	$	74,378		$	76,920

As of March 31, 2019 and December 31, 2018, total right-of-use assets related to finance leases were $1.2 million and $1.2 million respectively, and were classified as computers and equipment. Accumulated depreciation for assets under finance leases was $0.9 million and $0.8 million at March 31, 2019 and December 31, 2018 respectively.

The Company capitalized software development costs of $4.4 million and $5.7 million for the three months ended March 31, 2019 and 2018, respectively. Amortization expense related to capitalized software development costs was $4.5 million and $3.6 million for the three months ended March 31, 2019 and 2018, respectively. These costs are included in amortization expense in the condensed consolidated statements of income. At March 31, 2019, the unamortized software development costs included in property and equipment in the condensed consolidated balance sheets were $40.3 million.

Total depreciation expense plus amortization of capitalized software development costs, for the three months ended March 31, 2019 and 2018 was $8.2 million and $6.8 million, respectively.

16

Notes to Condensed Consolidated Financial Statements
(Unaudited)

Note 7Goodwill and Intangible Assets

Goodwill

There is no change in the carrying amount of goodwill for the three months ended March 31, 2019.

Intangible Assets

Acquired intangible assets at March 31, 2019 and December 31, 2018 were comprised of the following (in thousands):

	March 31, 2019							December 31, 2018
	Gross carrying amount		Accumulated amortization			Net		Gross carrying amount		Accumulated amortization			Net
Amortizable intangible assets:
Client/broker contracts and relationships	$	237,490	$	(114,920	)	$	122,570	$	237,430	$	(108,834	)	$	128,596
Trade names	3,880		(3,611		)	269		3,880		(3,587		)	293
Technology	14,646		(14,249		)	397		14,646		(14,009		)	637
Noncompete agreements	2,232		(2,102		)	130		2,232		(2,084		)	148
Favorable lease agreements	1,134		(738		)	396		1,134		(713		)	421
Total	$	259,382	$	(135,620	)	$	123,762	$	259,322	$	(129,227	)	$	130,095

Amortization of intangible assets for both the three months ended March 31, 2019 and 2018 was $6.4 million.

The estimated amortization expense in future periods at March 31, 2019 is as follows (in thousands):

	As of March 31, 2019
Remainder of 2019	$	18,552
2020	22,758
2021	19,953
2022	17,518
2023	14,728
Thereafter	30,253
Total	$	123,762

17

Notes to Condensed Consolidated Financial Statements
(Unaudited)

Note 8Accounts Payable and Accrued Expenses

Accounts payable and accrued expenses at March 31, 2019 and December 31, 2018 were comprised of the following (in thousands):

	March 31, 2019		December 31, 2018
Payable to benefit providers and transit agencies	$	26,952	$	32,771
Accounts payable and accrued liabilities	26,911		30,148
Accrued compensation and related benefits	29,064		28,594
Other accrued expenses	4,885		5,834
Accounts payable and accrued expenses	$	87,812	$	97,347

Note 9Long-term debt

As of March 31, 2019 and December 31, 2018, long-term debt consisted of the following (in thousands):

	March 31, 2019			December 31, 2018
Revolving credit facility used	$	189,830		$	249,830
Less: Outstanding letters of credit	(2,830		)	(2,830		)
Outstanding revolving credit facility	187,000			247,000
Unamortized loan origination fees	(2,231		)	(2,307		)
Long-term debt	$	184,769		$	244,693

On April 4, 2017, the Company entered into a Second Amended and Restated Credit Agreement (the “Credit Agreement”) with MUFG Union Bank, N.A., as administrative agent (“Agent”). The Credit Agreement amends and restates the Company’s existing Amended and Restated Credit Agreement, and increased the Company’s borrowing capacity under the revolving credit facility to $400.0 million, with a $15.0 million letter of credit sub-facility. The Credit Agreement contains an increase option permitting the Company, subject to certain conditions and requirements, to arrange with existing lenders and/or new lenders to provide up to an aggregate of $100.0 million in additional commitments. Loan proceeds may be used for general corporate purposes, including acquisitions permitted under the Credit Agreement. The Company may prepay loans under the Credit Agreement in whole or in part at any time without premium or penalty. The fees incurred in connection with this Credit Agreement are classified as a direct deduction from long-term debt in the condensed consolidated balance sheets. The Second Amended Credit Agreement contains financial and non-financial covenants including debt ratio and interest coverage ratio requirements. The Company is currently in compliance with all the covenants under the credit facility.

In the first quarter of 2019, the Company entered into a Third Reporting Extension Agreement and paid the Agent $0.1 million to extend the delivery date of the 2018 Annual Report on Form 10-K to May 10, 2019. In the second quarter of 2019, the Company entered into a Fourth Reporting Extension Agreement and paid the Agent $0.1 million to extend the delivery date of the 2018 Annual Report on Form 10-K to May 31, 2019. The fees incurred were added to loan financing fees to be amortized to interest expense over the remaining life of the loan. The 2018 Annual Report on Form 10-K was filed on May 29, 2019.

As of March 31, 2019, the Company had $187.0 million outstanding under the revolving credit facility and $210.0 million unused revolving credit facility still available to borrow under the Credit Agreement. As of March 31, 2019, the interest rate applicable to the revolving credit facility was 3.99% per annum.

18

Notes to Condensed Consolidated Financial Statements
(Unaudited)

Note 10Commitments and Contingencies

Operating Leases

The Company leases office space under noncancelable operating leases and leases various office equipment under finance lease arrangements. The Company’s leases have remaining lease terms of approximately 1 to 9 years, which may include the option to extend the lease when it is reasonably certain the Company will exercise that option. The exercise of lease renewal options is at the Company’s sole discretion. The components of operating lease expense were as follows (in thousands):

	Three Months Ended March 31, 2019
Operating lease cost	$	1,814
Sublease income	(468		)
Net lease cost	$	1,346

Rent expense under operating lease agreements was $1.5 million for the three months ended March 31, 2018.

Amortization and interest expense related to finance leases were not material during the three months ended March 31, 2019.

As of March 31, 2019, weighted-average remaining lease term and discount rate for the Company’s operating leases are 5.1 years and 4.6%, respectively.

As of March 31, 2019, maturities of lease liabilities by fiscal year for the Company’s operating leases, excluding the future contractual sublease income of $7.8 million, are as follows (in thousands):

Years Ending December 31,	Operating Leases
2019 (remainder of year)	$	7,154
2020	9,700
2021	9,696
2022	6,536
2023	2,308
Thereafter	5,663
Total minimum lease payments	41,057
Less: imputed interest	(4,533		)
Present value of net minimum lease payments	36,524
Less: current portion	8,069
Long-term operating lease liabilities	$	28,455

19

Notes to Condensed Consolidated Financial Statements
(Unaudited)

Prior to the adoption of the new leases standard, future minimum lease payments under non-cancelable operating leases, excluding the contractual sublease income of $8.3 million which is expected to be received through February 2023, were as follows as of December 31, 2018 (in thousands):

Years Ending December 31,	Operating Leases
2019	$	9,479
2020	9,685
2021	9,661
2022	6,536
2023	2,308
Thereafter	5,663
Total future minimum lease payments	$	43,332

Operating cash flows from operating leases were $2.3 million for the three months ended March 31, 2019.

During the second quarter of 2019, the Company entered into an approximately 10-year lease agreement to occupy 150,000 square feet of new office space in Mesa, AZ. The base rent obligation is expected to commence in the second quarter of 2020. In addition to the base rent payments, the Company will be obligated to pay certain customary amounts for its share of operating expenses and tax obligation. The Company has the option to extend the term of the lease for two additional five-year periods.

Legal Matters

The Company is pursuing affirmative claims against the Office of Personnel Management (OPM) to obtain payment for services provided by the Company between March 1, 2016 and August 31, 2016 pursuant to its contract with OPM for the Government’s Federal Flexible Account Program (“FSAFEDS”). The Company initially issued its invoice for these services in February 2017. On December 22, 2017, the Company received the Contracting Officer’s “final decision” refusing payment of the invoiced amount and otherwise denying the Company’s Certified Claim. As a result of this decision, and a related Certified Claim that OPM subsequently denied, on February 8, 2018, the Company filed an appeal to the Civilian Board of Contract Appeals (“CBCA”) against OPM for services provided by the Company between March 1, 2016 and August 31, 2016. On August 3, 2018, the Company also filed an appeal to the CBCA of OPM’s June 21, 2018 denial of a Request for Equitable Adjustment for extra work associated with a contract modification imposing new security and other requirements not part of the original scope of FSAFED’s contract work. In connection with the Company’s claims against OPM, OPM has also claimed that an erroneous statement in a certificate signed by a former executive officer constituted a violation of the False Claims Act and moved to dismiss part of the Company’s claim against OPM as a result. In March 2019, the Company filed a Motion for Summary Judgement with CBCA on the December 22nd denial by the OPM. OPM has moved to defer consideration of the Summary Judgment Motion to permit it further discovery. That Motion has been briefed and the case is on hold pending a ruling by the CBCA which could be handed down any day. In order to accelerate resolution of all matters before the CBCA, the Company’s appeal of the June 21st denial by the OPM was withdrawn on April 9, 2019. The remaining claim related to the OPM’s December 22nd denial, valued at approximately $6.2 million, is scheduled to go to trial in July 2019 if the pending Summary Judgment is denied by the CBCA. As with all legal proceedings, no assurance can be provided as to the outcome of these matters or if the Company will be successful in recovering the full claimed amount.

On March 9, 2018, a putative class action was filed in the United States District Court for the Northern District of California (the “Securities Class Action”). On May 16, 2019, a consolidated amended complaint was filed by the lead plaintiffs asserting claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, as amended, against the Company, its former Chief Executive Officer and its former Chief Financial Officer on behalf of purchasers of

20

Notes to Condensed Consolidated Financial Statements
(Unaudited)

WageWorks common stock between May 6, 2016 and March 1, 2018. The complaint also alleges claims under the Securities Act of 1933, as amended, arising from the Company’s June 19, 2017 common stock offering against those same defendants, as well as the members of its Board of Directors at the time of that offering and the underwriters of the offering.

On June 22, 2018 and September 6, 2018, two derivative lawsuits were filed against certain of our officers and directors and the Company (as nominal defendant) in the Superior Court of the State of California, County of San Mateo. The actions were consolidated. On July 23, 2018, a similar derivative lawsuit was filed against certain of our officers and directors and the Company (as nominal defendant) in the United States District Court for the Northern District of California (together, the “Derivative Suits”).

The Derivative Suits purport to allege claims related to breaches of fiduciary duties, waste of corporate assets, and unjust enrichment. In addition, the complaint in District Court includes a claim for abuse of control, and the complaint in Superior Court includes a claim to require the Company to hold an annual shareholder meeting. The allegations in the Derivative Suits relate to substantially the same facts as those underlying the Securities Class Action described above. The plaintiffs seek unspecified damages and fees and costs. In addition, the complaint in the Superior Court seeks for us to provide past operational reports and financial statements, to publish timely and accurate operational reports and financial statements going forward, to hold an annual shareholder meeting, and to take steps to improve its corporate governance and internal procedures.

Plaintiffs in the Superior Court action filed a Consolidated Complaint on May 2, 2019. As stipulated by the parties, and approved by the District Court, the District Court action is stayed. The parties in the District Court action are to notify the District Court within 15 days of (1) the dismissal of the Securities Class Action, (2) the denial of defendants’ motion(s) to dismiss, or (3) a party giving notice that they no longer consent to the voluntary stay.

The Company voluntarily contacted the San Francisco office of the SEC Division of Enforcement regarding the restatement and independent investigation. The Company is providing information and documents to the SEC and will continue to cooperate with the SEC’s investigation into these matters. The U.S. Attorney’s Office for the Northern District of California also opened an investigation. The Company has provided documents and information to the U.S. Attorney’s Office and will continue to cooperate with any inquiries by the U.S. Attorney’s Office regarding the matter.

The Company records a provision for contingent losses when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Based on currently available information, the Company does not believe that any additional liabilities relating to other unresolved matters are probable or that the amount of any resulting loss is estimable. In addition, in accordance with the relevant authoritative guidance, for matters which the likelihood of material loss is at least reasonably possible, the Company provides disclosure of the possible loss or range of loss. If a reasonable estimate cannot be made, the Company will provide disclosure to that effect. However, litigation is subject to inherent uncertainties and the Company’s view of these matters may change in the future. Were an unfavorable outcome to occur, there exists the possibility of a material adverse impact on the Company’s financial position, results of operations or cash flows for the period in which the unfavorable outcome occurs, and potentially in future periods.

The Company is involved in various other litigation, governmental proceedings and claims, not described above, that arise in the normal course of business. While it is not possible to determine the ultimate outcome or the duration of such litigation, governmental proceedings or claims, the Company believes, based on current knowledge and the advice of counsel, that such litigation, proceedings and claims will not have a material impact on the Company’s financial position or results of operations.

Note 11Stockholders’ Equity

Share Repurchase Program

On August 6, 2015, the Company’s Board of Directors authorized a $100 million stock repurchase program for 3 years which commenced on November 5, 2015 and expired on November 4, 2018. There were no shares of common stock repurchased during the three months ended March 31, 2018.

21

Notes to Condensed Consolidated Financial Statements
(Unaudited)

On March 11, 2019, the Company’s Board of Directors authorized a $150 million stock repurchase program for 3 years which commenced on March 13, 2019 and expires on March 12, 2022. Stock repurchases may be made from time-to-time in open market transactions, privately negotiated transactions, through accelerated share repurchase programs, or by any combination of such methods. The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including the Company’s stock price, corporate and regulatory requirements, restrictions under its debt obligations and other market and economic conditions. No shares of common stock have been repurchased under this program to date.

Note 12Employee Benefit Plans

Stock-based compensation

Stock-based compensation is classified in the condensed consolidated statements of income in the same expense line items as cash compensation. Amounts recorded as expense in the condensed consolidated statements of income were as follows (in thousands):

	Three Months Ended March 31,
	2019		2018
Cost of revenues	$	525	$	1,667
Technology and development	515		575
Sales and marketing	631		978
General and administrative	1,233		4,073
Total	$	2,904	$	7,293

(a)Employee Stock Option Plan

In May 2010, the Company adopted the 2010 Equity Incentive Plan (“2010 Plan”). Under the 2010 Plan, the Company can grant share-based awards to all employees, including executive officers, outside consultants and non-employee directors. Options under 2010 Plan generally has a term of 10 years and vest over 4 years with 25% vesting after one year of service and monthly vesting over the remaining period. As of March 31, 2019, the 2010 Plan has a total of 5.4 million common stock shares available for issuance.

There were no stock options granted in the first quarter of 2018 or 2019.

Stock option activity for the three months ended March 31, 2019 was as follows (shares in thousands):

	Shares		Weighted- average exercise price		Remaining contractual term (in years)	Aggregate intrinsic value (in thousands)
Outstanding at December 31, 2018	2,219		$	46.50	5.11	$	4,321
Granted	—
Exercised	—
Forfeited and cancelled	(4	)	$	53.47
Outstanding as of March 31, 2019	2,215		$	46.49	4.82	$	8,892
Vested and expected to vest at March 31, 2019	2,189		$	46.32	4.79	$	8,895
Exercisable at March 31, 2019	1,914		$	44.16	4.43	$	8,895

22

Notes to Condensed Consolidated Financial Statements
(Unaudited)

As of March 31, 2019, there was $6.3 million of total unrecognized stock-based compensation expense associated with stock options which will be recognized over a weighted-average period of approximately 1 year.  Total unrecognized compensation cost will be adjusted for future changes in estimated forfeitures.

(b)Restricted Stock Units

The Company grants restricted stock units (“RSU”) to certain employees, officers, and directors under the 2010 Plan. Restricted stock units vest upon performance-based or service-based criteria.

During the three months ended March 31, 2019 and 2018, the company granted zero performance-based restricted stock units. Performance-based restricted stock units are typically granted such that they vest upon the achievement of certain revenue growth rates and other financial metrics during a specified performance period for which participants have the ability to receive up to 200% of the target number of shares originally granted, depending on terms of the grant agreement.

Stock-based compensation expense related to restricted stock units was $1.5 million and $4.1 million for the three months ended March 31, 2019 and 2018, respectively. Total unrecorded stock-based compensation expense at March 31, 2019 associated with restricted stock units was estimated at $7.9 million, which is expected to be recognized over a weighted-average period of approximately 1 year.

The following table summarizes information about restricted stock units issued to officers, directors and employees under the 2010 Plan (shares in thousands):

					Weighted-average grant date fair value
	Service- based RSUs		Performance- based RSUs		Service- based RSUs		Performance- based RSUs
Unvested at December 31, 2018	164		200		$	61.79	$	59.76
Granted	—		—		—		—
Vested	(11	)	(88	)	$	55.86	$	43.63
Forfeited and cancelled	(4	)	—		$	60.58	$	—
Unvested at March 31, 2019	149		112		$	62.26	$	72.30

As of March 31, 2019, there were 0.1 million and 0.4 million cumulative vested Service-based and Performed-based RSUs which were not yet released due to the Company’s delay in filing its SEC reports.

Note 13Income Taxes

The Company reports income taxes using an asset and liability approach, under which deferred income taxes are provided based upon enacted tax laws and rates applicable to periods in which the taxes become payable. The Company is subject to income taxes in the U.S. federal and various state jurisdictions. Presently, there are no income tax examinations on-going in the jurisdictions where the Company operates.

The Company’s effective tax rate was 25.9% and 20.6% for the three months ended March 31, 2019 and 2018, respectively. The income tax provision for the three months ended March 31, 2019 and 2018 was $1.4 million and $2.9 million, respectively.

As of March 31, 2019, the Company remains in a net deferred tax asset position. The realization of the Company’s deferred tax assets depends primarily on its ability to generate sufficient U.S. taxable income in future periods. The amount of deferred tax assets considered realizable may increase or decrease in subsequent quarters as management reevaluates the underlying basis for the estimates of future domestic taxable income.

23

Notes to Condensed Consolidated Financial Statements
(Unaudited)

Note 14Subsequent Events

On June 27, 2019, the Company announced that it entered into a definitive agreement under which HealthEquity, Inc. will acquire all of its issued and outstanding shares of common stock for $51.35 per share in cash.

On May 23, 2019, each of our executive officers (other than our Executive Chairman and CEO) entered into a change in control and severance agreement.

In June 2019, the Board of Directors approved a grant of 728,297 RSUs to directors, executives, and employees of the Company.

24